Eliav Assouline and Marc Andersen's hedge fund Axial Capital have just filed a Form 4 with the SEC regarding transactions in shares of QLT Inc (QLTI). They purchased shares on October 29th, November 1st, and November 2nd. Cumulatively, they bought 171,000 shares with the bulk bought at $5.62 and $5.70. After their recent transactions, Axial now owns 6,786,036 QLTI shares.
Market Folly has cited Axial's previous QLTI purchases as the hedge fund seems happy to buy shares around the $5.60-5.75 level. Some investors have categorized QLT Inc as a 'cigarette butt' type of value investment as it's mainly a play on the company's royalty stream. Detractors argue that this stream is likely to decline. Assouline and Andersen see some value here though as evidenced by their continual buying.
Their hedge fund, Axial Capital, was seeded by Julian Robertson in 2005 and they share the same address as Tiger Management. Robertson has seeded/spawned a network of hedge fund managers which you can view at the Tiger family tree.
Taken from Google Finance:
QLT is a biotechnology company. The Company is engaged in the development and commercialization of therapies for the eye. The Company focuses on its commercial product, Visudyne, for the treatment of wet age-related macular degeneration (wet AMD), and developing its ophthalmic product candidates.